Chronopharmacology of dapagliflozin-induced antihyperglycemic effects in C57BL/6J mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronopharmacology of dapagliflozin-induced antihyperglycemic effects in C57BL/6J mice

Published:2019-09 Issue:5 Volume:13 Page:505-510
ISSN:1871-403X
Container-title:Obesity Research & Clinical Practice
language:en
Short-container-title:Obesity Research & Clinical Practice

Author:

Yoshioka Hiroki,Ohishi Rurika,Hirose Yui,Torii-Goto Aya,Park Sang Jun,Miura Nobuhiko,Yoshikawa Masae

Funder

Kinjo Gakuin University

Publisher

Elsevier BV

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism

Reference25 articles.

1. Exercise training-induced changes in MicroRNAs: beneficial regulatory effects in hypertension, type 2 diabetes, and obesity;Improta Caria;Int J Mol Sci,2018

2. Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?;Majumdar;Endocrine,2013

3. Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug;Idris;Diabetes Obes Metab,2009

4. Metabolic effects of antidiabetic drugs on adipocytes and adipokine expression;Yaribeygi;J Cell Physiol,2019

5. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications;Longo;Int J Mol Sci,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dapagliflozin promotes browning of white adipose tissue through the FGFR1-LKB1-AMPK signaling pathway;Molecular Biology Reports;2024-04-21

2. Dosing Time-Dependent Difference in the Suppressive Effect of Empagliflozin on the Development of Mechanical Pain Hypersensitivity in Diabetic Mice;Journal of Pharmacology and Experimental Therapeutics;2024-03-08

3. Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice;Frontiers in Endocrinology;2023-01-26

4. Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists;Diabetes, Obesity and Metabolism;2022-08-11

5. The effect of morning versus evening administration of empagliflozin on its pharmacokinetics and pharmacodynamics characteristics in healthy adults: a two-way crossover, non-randomised trial;F1000Research;2021-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3